RedChip Weekly Newsletter

Medalist Diversified REIT (NASDAQ: MDRR) Announces Cash Dividend of $0.175 Per Share

Medalist Diversified REIT (NASDAQ: MDRR), a Virginia-based real estate investment trust that specializes in acquiring, owning and managing value-add commercial real estate in the Southeast region of the U.S., announced a quarterly cash dividend on its common stock in the amount of $0.175 per share.

Why It Matters: This is the fourth consecutive quarterly dividend of $0.175 paid by MDRR since its IPO in November 2018. The Q3 2019 Dividend will be payable in cash on December 4, 2019 to holders of record of the Common Stock as of November 13, 2019.

The Backstory: MDRR is a Virginia-based real estate investment trust that specializes in acquiring, owning and managing value-add commercial real estate in the Mid-Atlantic and Southeast regions. The Company’s strategy is to focus on value-add and opportunistic commercial real estate which is expected to provide an attractive balance of risk and returns. Medalist utilizes a rigorous, consistent and replicable process for sourcing and conducting due diligence of acquisitions. The Company seeks to maximize operating performance of current properties by utilizing a hands-on approach to property management while monitoring the middle market real estate markets in the southeast for acquisition opportunities and disposal of properties as considered appropriate.

Disclosure

Medalist Diversified REIT (NASDAQ: MDRR) is a client of RedChip Companies, Inc. MDRR agreed to pay RedChip Companies, Inc. a monthly cash fee for four (4) months of RedChip investor awareness services.

Piedmont Lithium (NASDAQ: PLL) Partners with AMCI to Market By-Products

Piedmont Lithium (NASDAQ: PLL) announced a Letter of Intent (LOI) to partner with Ion Carbon & Minerals (Ion) to market the quartz, feldspar, and mica produced at the Company’s lithium development project in North Carolina.

Why It Matters: Ion is wholly owned by the AMCI Group, a leading specialist natural resources investor and marketer with a long-standing track record of success across a broad range of commodities. Ion has an extensive client base in North America which Piedmont and Ion will leverage to gain access to regional industrial minerals markets in the United States.

Key Quote: “We are very pleased to be partnering with Ion to develop the markets for our important mineral by-products. Quartz, feldspar and mica represented a significant proportion of the revenue for the lithium mines operated in North Carolina from the 1950s to the 1990s.” – Keith Phillips, President & CEO

The Backstory: PLL holds a 100% interest in the Piedmont Lithium Project located within the world-class Carolina Tin Spodumene Belt (“TSB”) and along trend to the Hallman Beam and Kings Mountain mines, historically providing most of the western world’s lithium between the 1950s and the 1980s. The TSB has been described as one of the largest lithium provinces in the world and is located approximately 25 miles west of Charlotte, North Carolina. It is a premier location for development of an integrated lithium business based on its favorable geology, proven metallurgy and easy access to infrastructure, power, R&D centers for lithium and battery storage, major high-tech population centers and downstream lithium processing facilities.

Disclosure

Piedmont Lithium (NASDAQ: PLL) is a client of RedChip Companies, Inc. PLL agreed to pay RedChip Companies, Inc. a monthly cash fee for six (6) months of RedChip investor awareness services.

Dog the Bounty Hunter Films Marketing Spots for Ethema’s (OTCQB: GRST) ARIA Treatment Center

Ethema Health (OTCQB: GRST) announced that Duane “Dog” Chapman, star of Dog’s Most Wanted airing on WGN America, spent several days in Florida visiting the GRST campus and filming material for commercials endorsing ARIA.

Why It Matters: Chapman has built a reputation of helping people turn their lives around, especially those suffering from addiction. His personal story is one of recovery and redemption, and he has endorsed ARIA as a unique and compassionate recovery center for helping those struggling with addiction. ARIA has built a program of care that ensures that its clients will receive long-term care through a combination of residential care and virtual long-term outpatient care. ARIA’s first facility is a 120-bed treatment center in West Palm Beach, Florida, with a team of employees dedicated to helping individuals live better lives free from

Key Quote: “We were fortunate to spend a few days with Dog and were very pleased to see how passionate his fans are. Our clientele was very excited to hear him speak and were very inspired by his passion for recovery.” – Shawn Leon, CEO

The Backstory: GRST operates in the behavioral healthcare space specifically in the treatment of substance use disorders. GRST developed a unique style of treatment over the last six years and has had much success with in-patient treatment for adults. GRST will continue to develop world-class programs and techniques with its expansion in the United States. The Company currently has under thirty employees and operates in West Palm Beach, Florida.

Watch our video to learn more

Disclosure

Ethema Health Corp. (OTCQB: GRST) is a client of RedChip Companies. GRST agreed to pay RedChip a monthly cash fee 150,000 shares of Rule 144 stock, earned monthly, for six (6) months of RedChip investor awareness services.

Cyclo Therapeutics (OTCQB: CTDH) Prepares for Alzheimer’s Development Program After Success with First Patient

Cyclo Therapeutics (OTCQB: CTDH), formerly CTD Holdings, is moving forward on the development of an Alzheimer's treatment using its proprietary Trappsol® Cyclo™ after reporting successful results from its first year of dosing of the drug in an Alzheimer's patient.

FDA authorization for a single patient IND expanded access program for Trappsol® Cyclo™, the company's proprietary formulation of hydroxypropyl beta cyclodextrin, was received for the treatment of late-onset Alzheimer's Disease in March 2018.

The company announced its first annual report with the FDA related to the program in June 2019. The one-year report described a favorable safety profile as well as encouraging initial observations on potential benefit.

"The report suggests cognitive and neurologic stability, indicating possible benefit," said Sharon Hrynkow PhD, CTDH's Chief Scientific Officer and Senior Vice President for Medical Affairs.

Commenting on the report, N. Scott Fine, CTDH's Chairman and CEO, added, "The data suggest a positive safety profile in this patient, overall stabilization of disease, and improvement in certain behavioral aspects of the disease."

Disclosure

Cyclo Therapeutics (CTDH) is a client of RedChip Companies. CTDH pays RedChip a monthly cash fee of between $15,000 and $30,000 for investor awareness services.